BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10532369)

  • 1. The management of nasolacrimal duct obstruction in children between 18 months and 4 years old.
    Kushner BJ
    J AAPOS; 1998 Feb; 2(1):57-60. PubMed ID: 10532369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon dacryocystoplasty as the primary treatment in older children with congenital nasolacrimal duct obstruction.
    Chen PL; Hsiao CH
    J AAPOS; 2005 Dec; 9(6):546-9. PubMed ID: 16414521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
    Honavar SG; Prakash VE; Rao GN
    Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success rate and cause of failure for late probing for congenital nasolacrimal duct obstruction.
    Maheshwari R
    J Pediatr Ophthalmol Strabismus; 2008; 45(3):168-71. PubMed ID: 18524195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasolacrimal Duct Probing for Young Children With Congenital Nasolacrimal Duct Obstructions in China: A 10-Year Systematic Review.
    Xiang Q; Gao X; Chen X; Qi J; Fang J
    J Pediatr Ophthalmol Strabismus; 2019 Nov; 56(6):365-372. PubMed ID: 31743404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Inferior Turbinate Fracture in the Management of Congenital Nasolacrimal Duct Obstruction.
    Rajabi MT; Inanloo B; Salabati M; Rafizadeh M; Tabatabaie SZ; Bayat R; Mahmoudzadeh R
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):269-271. PubMed ID: 30234839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferior turbinate fracture and congenital nasolacrimal duct obstruction.
    Attarzadeh A; Sajjadi M; Owji N; Reza Talebnejad M; Farvardin M; Attarzadeh A
    Eur J Ophthalmol; 2006; 16(4):520-4. PubMed ID: 16952088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat probing for treatment of persistent nasolacrimal duct obstruction.
    ; Repka MX; Chandler DL; Bremer DL; Collins ML; Lee DH
    J AAPOS; 2009 Jun; 13(3):306-7. PubMed ID: 19541274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results.
    Fayet B; Racy E; Ruban JM; Katowitz JA; Katowitz WR; Brémond-Gignac D
    J Fr Ophtalmol; 2021 May; 44(5):670-679. PubMed ID: 33836913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years.
    Une VL; Kulkarni SS; Nandedkar VS
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):141-145. PubMed ID: 31116859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
    ; Repka MX; Chandler DL; Beck RW; Crouch ER; Donahue S; Holmes JM; Lee K; Melia M; Quinn GE; Sala NA; Schloff S; Silbert DI; Wallace DK
    Ophthalmology; 2008 Mar; 115(3):577-584.e3. PubMed ID: 17996306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.